Impact of Diet-Modulated Butyrate Production on Intestinal Barrier Function and Inflammation.
Knud Erik Bach Knudsen,Helle Nygaard Lærke,Mette Skou Hedemann,Tina Skau Nielsen,Anne Krog Ingerslev,Ditte Søvsø Gundelund Nielsen,Peter Kappel Theil,Stig Purup,Stine Hald,Anne Grethe Schioldan,Maria L. Marco,Søren Gregersen,Kjeld Hermansen +12 more
Reads0
Chats0
TLDR
The effect of butyrate seems generally to be more consistent and positive oninflammatory markers related to the gut than on inflammatory markers in the peripheral tissue, and this discrepancy may be explained by differences inbutyrate concentrations in the gut compared with the much lower concentration at more remote sites.Abstract:
A major challenge in affluent societies is the increase in disorders related to gut and metabolic health. Chronic over nutrition by unhealthy foods high in energy, fat, and sugar, and low in dietary fibre is a key environmental factor responsible for this development, which may cause local and systemic inflammation. A low intake of dietary fibre is a limiting factor for maintaining a viable and diverse microbiota and production of short-chain fatty acids in the gut. A suppressed production of butyrate is crucial, as this short-chain fatty acid (SCFA) can play a key role not only in colonic health and function but also at the systemic level. At both sites, the mode of action is through mediation of signalling pathways involving nuclear NF-κB and inhibition of histone deacetylase. The intake and composition of dietary fibre modulate production of butyrate in the large intestine. While butyrate production is easily adjustable it is more variable how it influences gut barrier function and inflammatory markers in the gut and periphery. The effect of butyrate seems generally to be more consistent and positive on inflammatory markers related to the gut than on inflammatory markers in the peripheral tissue. This discrepancy may be explained by differences in butyrate concentrations in the gut compared with the much lower concentration at more remote sites.read more
Citations
More filters
Journal ArticleDOI
The health benefits of dietary fibre
TL;DR: Given the plethora of scientific evidence that corroborate the multiple and varied health benefits of dietary fibre, and the risks associated with a diet that lacks fibre, the optimization of fibre within the authors' diets represents an important public health strategy to improve both metabolic and overall health.
Journal ArticleDOI
Secondary Bile Acids and Short Chain Fatty Acids in the Colon: A Focus on Colonic Microbiome, Cell Proliferation, Inflammation, and Cancer.
TL;DR: Elucidation of the molecular events by which secondary BAs and SCFAs regulate colonic cell proliferation and inflammation will lead to a better understanding of the anticancer potential of dietary fiber in the context of high-fat diet-related colon cancer.
Journal ArticleDOI
The Intestinal Barrier and Current Techniques for the Assessment of Gut Permeability
Ida Schoultz,Åsa V. Keita +1 more
TL;DR: In vivo, in vitro and ex vivo techniques and how these methods can be utilized for thorough investigation of the intestinal barrier are outlined and discussed.
Journal ArticleDOI
Resistant starch: impact on the gut microbiome and health.
Peter DeMartino,Darrell Cockburn +1 more
TL;DR: Research on this interaction between resistant starch and the microbiota is using in vitro fermentations, cross-over design clinical trials and mouse studies with isotopically labeled starch, demonstrating that more personalized approaches are needed for finding resistant starch or other fiber that will promote a healthy gut.
Journal ArticleDOI
Relationships of gut microbiota, short-chain fatty acids, inflammation, and the gut barrier in Parkinson's disease.
Velma T. E. Aho,Madelyn C. Houser,Pedro Ab Pereira,Jianjun Chang,Knut Rudi,Lars Paulin,Vicki S. Hertzberg,Petri Auvinen,Malú G. Tansey,Malú G. Tansey,Filip Scheperjans +10 more
TL;DR: In this article, the authors compared and identified associations among these factors in Parkinson's disease patients and controls to elucidate their interrelations and links to clinical manifestations of PD Stool and plasma samples and clinical data were collected from 55 PD patients and 56 controls, and the results revealed potential alterations in microbiota-host interactions and links between earlier PD onset and intestinal inflammatory responses and reduced SCFA levels.
References
More filters
Journal ArticleDOI
Metabolic endotoxemia initiates obesity and insulin resistance
Patrice D. Cani,Jacques Amar,Miguel A. Iglesias,Marjorie Poggi,Claude Knauf,Delphine Bastelica,Audrey M. Neyrinck,Francesca Fava,Kieran Tuohy,Chantal Chabo,Aurélie Waget,Evelyne Delmée,Béatrice Cousin,Thierry Sulpice,Bernard Chamontin,Jean Ferrières,Jean-François Tanti,Glenn R. Gibson,Louis Casteilla,Nathalie M. Delzenne,Marie-Christine Alessi,Rémy Burcelin +21 more
TL;DR: It is concluded that the LPS/CD14 system sets the tone of insulin sensitivity and the onset of diabetes and obesity and lowering plasma LPS concentration could be a potent strategy for the control of metabolic diseases.
Journal ArticleDOI
From Dietary Fiber to Host Physiology: Short-Chain Fatty Acids as Key Bacterial Metabolites
TL;DR: Data is reviewed supporting the diverse functional roles carried out by a major class of bacterial metabolites, the short-chain fatty acids (SCFAs), which affect various physiological processes and may contribute to health and disease.
Journal ArticleDOI
Adipocytokines: mediators linking adipose tissue, inflammation and immunity.
TL;DR: Several adipocytokines have a central role in the regulation of insulin resistance, as well as many aspects of inflammation and immunity, and understanding this rapidly growing family of mainly adipocyte-derived mediators might be of importance in the development of new therapies for obesity-associated diseases.
Journal ArticleDOI
Short chain fatty acids in human large intestine, portal, hepatic and venous blood.
TL;DR: Data indicate that substantial carbohydrate, and possibly protein, fermentation is occurring in the human large intestine, principally in the caecum and ascending colon and that the large bowel may have a greater role to play in digestion than has previously been ascribed to it.
Journal ArticleDOI
Energy contributions of volatile fatty acids from the gastrointestinal tract in various species
TL;DR: The VFA, also known as short-chain fatty acids, are produced in the gastrointestinal tract by microbial fermentation of carbohydrates and endogenous substrates, such as mucus and may indirectly influence cholesterol synthesis and even help regulate insulin or glucagon secretion.